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108 Reduced effect of intravenous antibiotic treatment on sinonasal
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Objectives: Chronic rhinosinusitis promoted by upper airway (UAW) colonization
with pathogens like P. aeruginosa and S. aureus is a hallmark of CF. While
pulmonary therapy with antibiotics has been intensively studied, UAW effects
received little attention. Aims of the present trial are to compare early dynamics of
inﬂammatory markers in the UAW and lower airways (LAW) during IV-antibiotic
therapy.
Methods: Changes of inﬂammatory markers in both airway segments were assessed
in 16 CF patients receiving IV-antibiotic treatment against P. aeruginosa and/or
S. aureus over 14 days (median after 7.5 days). Non invasive sampling methods
were applied (nasal lavage with 10mL of isotonic saline/nostril, respectively induced
sputum). Cytology and interleukins (IL)-4, IL-8, IL-13, MPO, MMP-9, TIMP-1,
CTSS, NE were analyzed.
Results: Antibiotic therapy for 7.5 days signiﬁcantly reduced total cell count in
LAW but not in UAW. MPO and IL-8 decreased signiﬁcantly in both, the UAW and
LAW. Interestingly, this was much more pronounced for LAW (median decrease of
MPO: LAW 9.8fold resp. UAW 1.75fold; IL-8: LAW 3fold resp. UAW 1.9fold).
Conclusion: Although some inﬂammatory markers decreased in both airway levels
early during IV-antibiotic treatment responses in the UAW were relevantly reduced,
compared to pulmonary effects. Our ﬁndings highlight limitations of systemic
antibiotic treatment in the sinonasal compartment. Obviously, paranasal sinuses,
which are hollow organs often ﬁlled with pus, mucoceles, and polyps in CF are not
reached effectively by systemic antibiotic treatment. This ﬁnding is important for
treatment of bacterial rhinosinusitis in CF and other diseases.
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Exaggerated inﬂammatory responses to bacterial infections contribute to tissue
damage and pulmonary disease in cystic ﬁbrosis. Recently a growing body of
evidence suggests that dysregulated production of pro-inﬂammatory mediators by
macrophages might contribute to cystic ﬁbrosis lung pathology. While excessive
production of IL-6, GM-CSF, MCP-1 by human CF macrophages has been ascribed
to abnormal signalling and trafﬁcking of TLR4 following stimulation with LPS,
dysregulation in the constitutive secretion of other pro-inﬂammatory mediators,
such as IL-8, has been also reported. These data suggest that, dysfunctional CFTR
may affect multiple molecular pathways involved in cytokine expression. Thus the
aim of this study was to assess the impact of CFTR dysfunction in the production
of IL-8 by human macrophages. To this aim we quantiﬁed constitutive or LPS-
induced IL-8 secretion by human CF macrophages. The resulting data demonstrated
a signiﬁcant increase in the constitutive production of IL-8 by CF macrophages
with respect to control cells while no differences were observed following LPS
stimulation between the two groups (CF versus non-CF). Quantitative analysis of
IL-8 mRNA by real time PCR conﬁrmed an increase in the chemokine transcript
in CF macrophages. Similarly, treatment of non-CF macrophages with the CFTR
inhibitor CFTRinh−172 led to a signiﬁcant increase in IL-8 transcripts indicating that
the absence of CFTR function is sufﬁcient to alter IL-8 transcription. Current studies
focus on the identiﬁcation of transcription factors responsible for the augmented
IL-8 expression in human macrophages carrying dysfunctional CFTR.
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Objectives: The zinc ﬁnger protein A20 negatively regulates inﬂammatory NF-kB
signalling, but in CF A20 expression/function is signiﬁcantly reduced (Kelly et al.
2012, 2013) and preliminary data suggest that A20 up-regulation can normalise
inﬂammation.
Methods: To predict further small molecules that would induce A20, we employed
an advanced bioinformatics technique (Connectivity Mapping, CM). CM can
establish the connection between different biological states based on their gene
expression proﬁles. Using six independent public genome expression data sets A20
was used as the seed gene to create a gene expression proﬁle. CM analysis then
identiﬁed its closest associates (genes behaving similar to A20 in CF).
Results: The ‘A20 associated’ genes are activating transcription factor 3 (ATF3),
intercellular adhesion molecul-1 (ICAM1), a member of the RAS oncogene fam-
ily (RAB5C), nuclear envelope pore membrane protein (POM121), presenilin 1
(PSEN1) and domain containing protein 4A (DENND4A). Quantitative RT-PCR
analyses in 16HBE14o− and CFBE41o− conﬁrmed reduced basal expression and a
delayed and lower LPS-induced expression of these genes, similarly to A20 (Kelly
et al. 2012), given further conﬁdence in the approach.
Conclusion: Together with A20, these ‘A20 associates’ then served as an input
to the CM process (www.broadinstitute.org) to predict small molecule compounds
already licensed for the use in humans that enhance A20 expression. Future work
will determine A20-inducing and anti-inﬂammatory effects of these drugs, which
could then be used as alternative anti-inﬂammatory therapies (drug repositioning).
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Pathogen-induced acute and chronic airway inﬂammation is driven by activation of
the transcription factor NF-úB. To ensure termination of the inﬂammatory response
NF-kB signalling is tightly regulated. The zinc ﬁnger protein A20 negatively
regulates NF-úB signalling through interaction with various signalling partners.
In Cystic Fibrosis chronic airway inﬂammation, A20 expression and function are
signiﬁcantly reduced (Kelly et al. 2012) and this lack is associated with reduced
lung function (Kelly et al. 2013). The plant diterpene gibberellin (GA3) has been
described to induce Zn-Finger like proteins in plants and have anti-inﬂammatory
properties in mice.
We hypothesized that GA3 works via an A20-dependent mechanism and examined
the effects on airways inﬂammation in CF in-vitro.
14HBE16o− and CFBE41o cells were stimulated with LPS in the presence or
absence of GA3. IL-8 release and NF-úB activation were determined. Further
studies employed siRNA.
Our results show that in CF and non-CF cell lines GA3 (30mM) protects cells against
LPS-stimulated IL-8 release by induction of A20. In 14HBE16o− this action was
accompanied by reduced p65 expression and increased IkBa abundance. Silencing
of A20 using siRNA showed that this effect was A20-dependent. The effect and
mechanism of GA3 was conﬁrmed in non-CF primary nasal epithelial cells.
Future work will determine the efﬁcacy of GA3 to overcome defective A20
signalling in CF chronic airways disease.
